Subvolts take OpenAI's leaders discuss AI's role in accelerating life sciences research and drug discovery. Apr 16, 2026 - Developers
- Learn about the specific challenges and opportunities in applying AI to life sciences research and development.
- Business
- Understand how AI is poised to transform drug discovery and lab automation, creating new business models and efficiencies.
This is a solid interview with key OpenAI researchers discussing AI's application in a critical scientific field.
Building AI for Life Sciences - Episode 16
Audio streams from OpenAI. Your place is remembered on this device.
From Subvolts
Summary and analysis by Subvolts editorial, AI-assisted.
The OpenAI Podcast episode "Building AI for Life Sciences" features research lead Joy Jiao and product lead Yunyun Wang discussing OpenAI's development of AI models for life sciences. They cover responsible deployment, current research workflow improvements, and future applications in drug discovery and autonomous labs. The conversation also touches on biosecurity risks and the role of compute in scientific advancement.
This episode talks about how AI can help scientists work faster and discover new medicines. It explains how AI tools are being built to assist in labs, making research more efficient and potentially leading to breakthroughs in health.
This episode offers insight into how major AI labs like OpenAI are tackling complex scientific domains. It's for researchers, product managers, and anyone interested in AI's practical applications beyond consumer tech. The discussion on autonomous labs and drug discovery aligns with broader industry trends where AI is increasingly integrated into scientific infrastructure, mirroring efforts across Google Gemini and Anthropic to leverage AI for scientific breakthroughs.
- HostAndrew Mayne
- GuestJoy JiaoResearch lead, OpenAI
- GuestYunyun WangProduct lead, OpenAI
- Episode Title: Building AI for Life Sciences - Episode 16
- Show: The OpenAI Podcast
- Length: 44 minutes
- Guests: Joy Jiao (Research lead, OpenAI), Yunyun Wang (Product lead, OpenAI)
- Topics Covered: Responsible deployment, research workflows, drug discovery, autonomous labs, biosecurity, compute for science.
What does it take to build AI systems that can actually help scientists? Research lead Joy Jiao and product lead Yunyun Wang discuss how OpenAI is developing models for life sciences and what responsible deployment means in a field with real biosecurity stakes. They explore how AI is already improving research workflows and where it could lead in drug discovery and more autonomous labs — including why a future with less pipetting sounds pretty good to most scientists.
Chapters
0:39 Introducing the Life Sciences model series
3:47 Joy’s path into life sciences
5:00 Autonomous lab with Ginkgo Bioworks
7:27 Yunyun’s path into life sciences
8:12 OpenAI’s life sciences work
9:48 Biorisk, access, and safeguards
15:43 What models can do in the lab
17:51 Building scientific infrastructure
20:14 Why compute matters for science
24:54 Where are we in 6-12 months?
29:51 Scientific adoption and skepticism
33:17 Advice for students and researchers
40:27 Where are we in 10 years?
Hosted on Acast. See acast.com/privacy for more information.
- biosecurity
- Joy Jiao
- safety related to biological materials and information
- pipetting
- Yunyun Wang
- the process of transferring liquids using a tool called a pipette, common in labs
41 minWhat racing reveals about working with AI - Episode 22
WithJoyce Ruffell, Chase Holden
44 minWhy Tejal Patwardhan stopped underestimating the models - Episode 21
WithTejal Patwardhan
41 minHow a reasoning model cracked an 80-year-old math problem - Episode 20
WithAlexander Wei, Hongxun Wu, Lijie Chen
29 minInside image generation’s Renaissance moment - Episode 19
WithAdele Li, Kenji Hata
1 h 18John Ternus Takes Over Apple in the AI Era
WithJohn Ternus
1 h1 h#335 Sriram Raghavan: Why IBM Is Betting Everything on Small AI Models
WithSriram Raghavan
Questions people ask
- What is OpenAI doing in life sciences?
- OpenAI is developing AI models to help scientists improve research workflows, accelerate drug discovery, and create more autonomous labs.
- What are the risks of AI in life sciences?
- The episode discusses biorisk, access, and safeguards, highlighting the importance of responsible deployment in a field with significant biosecurity stakes.
Page generated Oct 19, 2026. Summaries are Subvolts' own; the audio, artwork and notes belong to OpenAI.